Flagship explainer
What drives Regenerative Medical Technology Group Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$7.8M | FY2025 |
| |
| Income before tax | −$9.5M | FY2025 |
|
| Operating income | −$867162 | FY2025 |
|
| $5.1M | FY2025 |
| |
| Ending assets | $4.5M | FY2025 |
|
| Beginning assets | $3.8M | FY2024 |
|
| −$34.7M | FY2025 |
| |
| −$27.4M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001213900-26-056841